Oral Anticoagulant, Direct-Acting

DRUG2 trials

Sponsors

Clinical Hospital Centre Zagreb, Assistance Publique - Hôpitaux de Paris

Conditions

Cardiovascular DrugsCryptogenic Ischemic StrokeDrug-Related Side Effects and Adverse ReactionsPatent Foramen OvalePharmacogenetics

Phase 3

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

RecruitingNCT05387954

Assistance Publique - Hôpitaux de ParisCryptogenic Ischemic Stroke, Patent Foramen Ovale

Start: 2023-07-07End: 2031-07-07Target: 792Updated: 2026-03-24

Unknown Phase

Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction

Clinical Hospital Centre ZagrebPharmacogenetics, Drug-Related Side Effects and Adverse Reactions, Cardiovascular Drugs

Start: 2020-12-15End: 2025-12-14Target: 1200Updated: 2022-04-01